Vysioneer LLC
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
VBrain applies auto-contouring to the three most common types of brain tumors: brain metastasis, meningioma and acoustic neuroma.
The content above was translated by Ai
Founded Year
2018
Unified Business No.
50892131
Status
Active
Number of Employees
0
Total capital
64,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Vysioneer is an oncology AI company with a mission to use machine learning to bring therapies to cancer patients in need sooner. Our journey began with the belief that every tumor matters in the fight against cancer.
Powered by our FDA-cleared, cloud-based AI platform, Vysioneer enhances drug efficacy with lesion-level precision, enabling pharma and clinicians to identify the right treatment for the right patient at the right time. Vysioneer is headquartered in Cambridge, MA.
Powered by our FDA-cleared, cloud-based AI platform, Vysioneer enhances drug efficacy with lesion-level precision, enabling pharma and clinicians to identify the right treatment for the right patient at the right time. Vysioneer is headquartered in Cambridge, MA.
The content above was translated by Ai
